» Authors » Ruth E Johnson

Ruth E Johnson

Explore the profile of Ruth E Johnson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 393
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Croghan I, Ghosh A, Fratianni A, Kuhle C, Johnson R, Hays J, et al.
J Prim Care Community Health . 2023 Sep; 14:21501319231197162. PMID: 37665267
This commentary offers the reader an alternative to mentoring through the use of PODCASTS. By providing the listener with an understanding of the challenges and opportunities for self-reflection and sharing...
2.
Delaney A, Howell C, Krull K, Brinkman T, Armstrong G, Chemaitilly W, et al.
J Natl Cancer Inst . 2021 Mar; 113(10):1415-1421. PMID: 33720359
Background: Some adult survivors of childhood cancers develop frailty at higher rates than expected based on their chronological age. This study examined the incidence of frailty among survivors at 10...
3.
Kermott C, Johnson R, Sood R, Jenkins S, Sood A
PLoS One . 2019 Jun; 14(6):e0218092. PMID: 31185049
Objective: To assess the impact of resilience, the ability to withstand and bounce back from adversity, on measures of well-being, self-reported stress, and mental health diagnoses. Methods: This study was...
4.
Williams K, Washington M, Johnson-Rouse T, Johnson R, Freeman C, Reed C, et al.
Appetite . 2015 Oct; 96:254-259. PMID: 26431682
Three experiments were done to better assess the gastrointestinal (GI) site(s) of action of GLP-1 on food intake in rats. First, near-spontaneous nocturnal chow meal size (MS), intermeal intervals (IMI)...
5.
Sayegh A, Washington M, Johnson R, Johnson-Rouse T, Freeman C, Harrison A, et al.
Horm Behav . 2014 Dec; 67:48-53. PMID: 25479193
The site(s) of action that control meal size and intermeal interval (IMI) length by cholecystokinin-58 (CCK-58), the only detectable endocrine form of CCK in the rat, are not known. To...
6.
Kermott C, Kuhle C, Faubion S, Johnson R, Hensrud D, Murad M
BMC Health Serv Res . 2012 Jun; 12:137. PMID: 22646664
Background: The benefits of a periodic health evaluation remain debatable. The incremental value added by such evaluations beyond the delivery of age appropriate screening and preventive medicine recommendations is unclear....
7.
Montori V, Shah N, Pencille L, Branda M, Van Houten H, Swiglo B, et al.
Am J Med . 2011 May; 124(6):549-56. PMID: 21605732
Objective: Poor adherence to therapy, perhaps related to unaddressed patient preferences, limits the effectiveness of osteoporosis treatment in at-risk women. A parallel patient-level randomized trial in primary care practices was...
8.
Iftikhar S, Shuster L, Johnson R, Jenkins S, Wahner-Roedler D
J Womens Health (Larchmt) . 2011 Apr; 20(4):559-65. PMID: 21486160
Background: We aimed to assess the frequency of and experiences with use of bioidentical compounded hormone therapy (BCH) by women seen at an academic women's health clinic and menopause center....
9.
Johnson R, Kermott C, Murad M
Ther Clin Risk Manag . 2011 Apr; 7:145-8. PMID: 21479145
Clinical Question: What is the best management approach for gynecomastia? Results: In most patients, surgical correction usually leads to immediate cosmetic and symptomatic improvement and is considered the best approach....
10.
Pencille L, Campbell M, Van Houten H, Shah N, Mullan R, Swiglo B, et al.
Trials . 2009 Dec; 10:113. PMID: 20003299
Background: Bisphosphonates can reduce fracture risk in patients with osteoporosis, but many at-risk patients do not start or adhere to these medications. The aims of this study are to: (1)...